Quick Answer
Travere Therapeutics, Inc. reported Shares Outstanding of 90.92 million shares for fiscal year 2025.
Travere Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 90.92M | +4.0% |
| 2024 | 87.45M | +16.0% |
| 2023 | 75.37M | +17.2% |
| 2022 | 64.29M | +2.9% |
| 2021 | 62.49M | +19.6% |
| 2020 | 52.25M | +21.3% |
| 2019 | 43.09M | +4.1% |
| 2018 | 41.39M | +5.1% |
| 2017 | 39.37M | +3.9% |
| 2016 | 37.91M | +4.0% |
| 2015 | 36.47M | +40.0% |
| 2014 | 26.05M | +41.4% |
| 2013 | 18.42M | +105.7% |
| 2012 | 8.95M | +121.5% |
| 2011 | 4.04M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 89.46M | +14.8% | +0.4% |
| June 30, 2025 | 89.10M | +16.5% | +0.4% |
| March 31, 2025 | 88.79M | +16.7% | +1.5% |
| December 31, 2024 | 87.45M | +16.0% | +12.2% |
| September 30, 2024 | 77.91M | +3.7% | +1.9% |
| June 30, 2024 | 76.46M | +2.0% | +0.5% |
| March 31, 2024 | 76.11M | +2.0% | +1.0% |
| December 31, 2023 | 75.37M | +17.2% | +0.3% |
- Travere Therapeutics, Inc. showed an increase of +4.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, Travere Therapeutics, Inc.’s shares outstanding has grown by 2149.3% (from 4.04 million shares to 90.92 million shares).
- The most recent figure is from Travere Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: